» Articles » PMID: 37992972

Association Between Public Health Policies on Alcohol and Worldwide Cancer, Liver Disease and Cardiovascular Disease Outcomes

Abstract

Background & Aims: The long-term impact of alcohol-related public health policies (PHPs) on disease burden is unclear. We aimed to assess the association between alcohol-related PHPs and alcohol-related health consequences.

Methods: We conducted an ecological multi-national study including 169 countries. We collected data on alcohol-related PHPs from the WHO Global Information System of Alcohol and Health 2010. Data on alcohol-related health consequences between 2010-2019 were obtained from the Global Burden of Disease database. We classified PHPs into five items, including criteria for low, moderate, and strong PHP establishment. We estimated an alcohol preparedness index (API) using multiple correspondence analysis (0 lowest and 100 highest establishment). We estimated an incidence rate ratio (IRR) for outcomes according to API using adjusted multilevel generalized linear models with a Poisson family distribution.

Results: The median API in the 169 countries was 54 [IQR 34.9-76.8]. The API was inversely associated with alcohol use disorder (AUD) prevalence (IRR 0.13; 95% CI 0.03-0.60; p = 0.010), alcohol-associated liver disease (ALD) mortality (IRR 0.14; 95% CI 0.03-0.79; p = 0.025), mortality due to neoplasms (IRR 0.09; 95% CI 0.02-0.40; p = 0.002), alcohol-attributable hepatocellular carcinoma (HCC) (IRR 0.13; 95% CI 0.02-0.65; p = 0.014), and cardiovascular diseases (IRR 0.09; 95% CI 0.02-0.41; p = 0.002). The highest associations were observed in the Americas, Africa, and Europe. These associations became stronger over time, and AUD prevalence was significantly lower after 2 years, while ALD mortality and alcohol-attributable HCC incidence decreased after 4 and 8 years from baseline API assessment, respectively (p <0.05).

Conclusions: The API is a valuable instrument to quantify the robustness of alcohol-related PHP establishment. Lower AUD prevalence and lower mortality related to ALD, neoplasms, alcohol-attributable HCC, and cardiovascular diseases were observed in countries with a higher API. Our results encourage the development and strengthening of alcohol-related policies worldwide.

Impact And Implications: We first developed an alcohol preparedness index, an instrument to assess the existence of alcohol-related public policies for each country. We then evaluated the long-term association of the country's alcohol preparedness index in 2010 with the burden of chronic liver disease, hepatocellular carcinoma, other neoplasms, and cardiovascular disease. The strengthening of alcohol-related public health policies could impact long-term mortality rates from cardiovascular disease, neoplasms, and liver disease. These conditions are the main contributors to the global burden of disease related to alcohol use. Over time, this association has not only persisted but also grown stronger. Our results expand the preliminary evidence regarding the importance of public health policies in controlling alcohol-related health consequences.

Citing Articles

The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021.

Tham E, Tan D, Danpanichkul P, Ng C, Syn N, Koh B Liver Int. 2025; 45(3):e70001.

PMID: 39927433 PMC: 11808647. DOI: 10.1111/liv.70001.


Evaluating the synergy: anxiety prevalence and alcohol consumption patterns in high-income countries using Granger causality analysis.

Senarathne B, Palliyaguru D, Oshini A, Gamage J, Jayathilaka R, Rajamanthri L BMC Public Health. 2025; 25(1):220.

PMID: 39828695 PMC: 11744946. DOI: 10.1186/s12889-025-21402-6.


Epidemiology and Outcomes of Alcohol-Associated Hepatitis in Adolescents and Young Adults.

Flemming J, Djerboua M, Chapman O, Ayonrinde O, Terrault N JAMA Netw Open. 2024; 7(12):e2452459.

PMID: 39729318 PMC: 11681377. DOI: 10.1001/jamanetworkopen.2024.52459.


Increased mortality from alcohol use disorder, alcohol-associated liver disease, and liver cancer from alcohol among older adults in the United States: 2000 to 2021.

Danpanichkul P, Duangsonk K, Tham E, Tothanarungroj P, Auttapracha T, Prasitsumrit V Alcohol Clin Exp Res (Hoboken). 2024; 49(2):368-378.

PMID: 39701596 PMC: 11828968. DOI: 10.1111/acer.15516.


Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria.

Diaz L, Lazarus J, Fuentes-Lopez E, Idalsoaga F, Ayares G, Desaleng H Commun Med (Lond). 2024; 4(1):219.

PMID: 39472739 PMC: 11522458. DOI: 10.1038/s43856-024-00649-x.